test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
ARVNArvinas Inc
Recent Activity
Decreased -49.89%
1.89%
$36.871M
1.497M shares@ $24.63 avg price
RVMDRevolution Medicines Inc
Recent Activity
Increased 4.64%
1.83%
$35.827M
790,000 shares@ $45.35 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
New Position
1.74%
$34.091M
2.132M shares@ $15.99 avg price
PHATPhathom Pharmaceuticals Inc
Recent Activity
Increased 11.39%
1.67%
$32.625M
1.804M shares@ $18.08 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 8.49%
1.65%
$32.205M
818,000 shares@ $39.37 avg price
AVTRAvantor Inc
Recent Activity
Decreased -59.98%
1.63%
$31.949M
1.235M shares@ $25.87 avg price
BPMCBlueprint Medicines Corp
Recent Activity
Decreased -17.75%
1.49%
$29.137M
315,000 shares@ $92.5 avg price
MIRMMirum Pharmaceuticals Inc
Recent Activity
1.46%
$28.513M
731,104 shares@ $39.0 avg price
SGRYSurgery Partners Inc
Recent Activity
Decreased -36.69%
1.37%
$26.662M
827,000 shares@ $32.24 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
Decreased -21.25%
1.36%
$26.611M
296,100 shares@ $89.87 avg price